Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Interleukin-10 polymorphisms, cancer susceptibility and prognosis

Lookup NU author(s): Dr William Howell

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Interleukin-10 (IL-10) is a multifunctional cytokine with both immunosuppressive and anti-angiogenic functions and may have both tumour-promoting and -inhibiting properties. A large number of polymorphisms (primarily single nucleotide polymorphisms (SNPs)) have been identified in the IL-10 gene promoter. Convincing evidence that certain of these polymorphisms are associated with differential expression of IL-10 in vitro and in some cases in vivo has been obtained and a number of studies have investigated associations between IL-10 polymorphisms and cancer susceptibility/prognosis. The results from 22 studies in 13 different malignancies are reviewed. In 17 of these studies, positive associations between IL-10 genotype or haplotype and disease susceptibility and/or progression were reported. In some of these cancers genotypes associated with low IL-10 expression were a risk factor for disease or disease progression, while in others genotypes associated with high IL-10 expression were a risk factor. Published findings in breast cancer are as yet conflicting. Most, but not all of the studies reviewed are based on small sample sizes and a limited number of IL-10 polymorphisms. However, the preliminary data obtained thus far indicate that larger studies are required in a number of cancers, in order to confirm initial results, extend studies to include more detailed genotype/haplotype analysis and combine genotype and gene expression studies in the same subjects. Such studies will contribute significantly to our understanding of the biological role of IL-10 in cancer development.

Publication metadata

Author(s): Howell WM, Rose-Zerilli MJ

Publication type: Article

Publication status: Published

Journal: Familial Cancer

Year: 2006

Volume: 5

Issue: 2

Pages: 143-149

Print publication date: 01/01/2006

ISSN (print): 1389-9600

ISSN (electronic): 1573-7292

Publisher: Springer

URL: http://dx.doi.org/10.1007/s10689-005-0072-3

DOI: 10.1007/s10689-005-0072-3

Altmetrics

Altmetrics provided by Altmetric

Share